Regulations
Rules and regulations governing the sale, safety and quality of nutraceutical ingredients and finished products are essential to market function worldwide. In this section, we provide you with the most up-to-date information on regulations impacting both dietary supplements and functional foods from all corners of the globe, including Western and Eastern Europe, Asia, North and South America, Australia/New Zealand and the Middle East.
- All
- Consumer Trends
- Contract Manufacturing
- Cosmeceuticals / Nutricosmetics
- Delivery & Dosage Technologies
- Dietary Supplements
- Flavors & Colors
- Functional Foods & Beverages
- Healthcare Trends
- Medical Nutrition
- Mergers & Acquisitions
- Natural/Organic
- Nutrition Bars & Snacks
- Packaging
- Pet Nutraceuticals
- Quality & Safety
- Regulations
- Research
- Testing
- World Markets
-
Dietary Supplements | Herbs & Botanicals | Regulations
CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
Stakeholders disappointed by agency inaction but welcome chance to influence legislation.Online Exclusives By Sean Moloughney, Editor 01.31.23
-
Dietary Supplements | Herbs & Botanicals | Regulations
Natural Products Association Blasts FDA for Punting CBD Issues to Congress
FDA rejected NPA’s petition that asked the agency to clear a regulatory pathway for CBD and to review safety data from cbdMD.Online Exclusives By Sean Moloughney, Editor 01.27.23
-
Dietary Supplements | Herbs & Botanicals | Regulations
FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
In response letters, agency says NDI process not robust enough to ensure applicable safety standards are met.Online Exclusives By Sean Moloughney, Editor 01.26.23
-
Consumer Trends | Dietary Supplements | Healthcare Trends | Regulations
2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy
Even amid a slowdown, consumer focus on health and wellness appears to be a fixture in the current economy.By Sean Moloughney, Editor 01.20.23
-
Healthcare Trends | Regulations | World Markets
A Bottleneck in Certification of Medical Devices Could Impact Patient Care in the EU
A proposed extension for the implementation period of new regulation might help, but companies need to be diligent.By Joerg Gruenwald, analyze & realize GmbH 01.20.23
-
Breaking News | Functional Foods & Beverages | Industry & Market News | Regulations | Vitamins
FDA to Allow Vitamin D3 as Additive in Cereals, Grain-Based Bars
The agency made an amendment to allow for the addition of D3 in specific food categories.01.18.23
-
Dietary Supplements | Regulations
Critiquing FTC’s New Health Products Compliance Guidance
The agency is acting like an overbearing parent, undermining its credibility by promulgating stringent regulations via suggestion without input from industry.By Todd Harrison, Partner, and Melanie English, Associate, Venable 01.12.23
-
Breaking News | Dietary Supplements | Regulations | Regulatory News | World Markets
FDA Issues Final Guidance for Foreign Supplier Verification Programs
Guidance includes recommendations on how to analyze hazards, evaluate a supplier’s performance and risk, and conduct appropriate verification activities.01.10.23
-
Dietary Supplements | Regulations | World Markets
Battles That Have United the Natural Products Industry—and Those Which Have Not
Looking back at the Vitamin Volstead Act, DSHEA, Codex, the AER Bill, and MPLsBy James J. Gormley, Gormley NPI Consulting 01.06.23
-
Dietary Supplements | Regulations | Weight Management/Weight Loss
Bill to Restrict Access to Supplements Vetoed in New York
Gov. Kathy Hochul claimed the bill was too burdensome on the Department of Health.Online Exclusives By Mike Montemarano, Associate Editor 01.03.23
-
Breaking News | Dietary Supplements | Regulations | Regulatory News
FTC Issues New Compliance Guidance for Marketing Health Products
Revised guide represents ‘a substantial update’ to the 1998 guide on advertising dietary supplements.01.03.23
-
Dietary Supplements | Regulations
Regulatory Challenges Persist for Dietary Supplement Stakeholders
Experts discussed structure-function claims, drug preclusion issues, and more at AHPA’s Regulatory Congress.Online Exclusives By Mike Montemarano, Associate Editor 12.20.22
-
Breaking News | Dietary Supplements | People News | Regulations
CRN Announces New Board Chair and Other Leadership Positions
Tara Martin, general counsel for Nutrawise/YouTheory, will chair the board of directors in 2023.12.19.22
-
Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Mergers & Acquisitions | Regulations
Top Trends in CBD: 2022 Market Year in Review
Regulatory uncertainty has held innovation back, but companies are moving forward with science and on-trend formulations.Online Exclusives By Sheldon Baker, Baker Dillon Group 12.19.22
-
Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations | Testing
BAPP Program Advances ‘Burn It, Don’t Return It’ Policies to Cut Herb Adulteration
The finalized SOP document represents the first set of best practices specifically focused on how to deal with defective raw materials.By Erik Goldman, Holistic Primary Care 12.01.22
-
Delivery & Dosage Technologies | Dietary Supplements | Quality & Safety | Regulations | Testing
State of the Industry: Inflation, Supply Chains, Quality Issues Top List of Concerns
Our fifth annual survey indicates companies continue to adapt to a challenging business environment, as market confidence remains high.By Sean Moloughney, Editor 12.01.22
-
Dietary Supplements | Herbs & Botanicals | Regulations
FDA Warning Letters Take Aim at Foods and Beverages Containing CBD
Recent batches of warning letters signal the agency’s focused on more than disease claims.Online Exclusives By Mike Montemarano, Associate Editor 11.28.22
-
Dietary Supplements | Regulations | Weight Management/Weight Loss
Weight Loss, Muscle Building In the Crosshairs
Experts discussed legislative efforts to restrict access to certain dietary supplement categories.Online Exclusives By Mike Montemarano, Associate Editor 11.28.22
-
Breaking News | Cardiovascular Health | Dietary Supplements | Industry & Market News | Regulations
FDA Warns Companies Allegedly Making Heart Disease Claims
The agency said seven companies with making claims pertaining to atherosclerosis, stroke, heart failure, and more.11.17.22
-
Dietary Supplements | Regulations
NDI Déjà vu: Another Ingredient Falls Victim to FDA’s Interpretation of Drug Preclusion Clause
Agency rejected an NDI notification from Kingdomway saying beta nicotinamide-mononucleotide was first investigated as a new drug.Online Exclusives By Mike Montemarano, Associate Editor 11.15.22
